AMGN Trading Analysis - 10/09/2026 01:57 PM — TRU-SENTIMENT

News Headlines & Context

The following items are based on general knowledge and are separated from the data-driven analysis below:

• Amgen (AMGN) recently presented positive Phase 3 data for its obesity asset, reinforcing pipeline momentum and drawing analyst attention.
• The company declared a quarterly dividend of $2.52 per share (ex-dividend date Aug 21, 2026), maintaining its $10.08 annualized rate.
• Biotech sector volatility increased amid FDA panel outcomes and broader pharma pricing debate in early October 2026.
• No confirmed near-term earnings date催化剂 in this window, but fiscal year-end was Dec 2025 per fundamentals.
• Headlines suggest fundamental stability, which contrasts with the bearish options sentiment seen in the embedded data.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data for AMGN:

• Trailing P/E: 25.10; Trailing EPS: $16.22; Market Cap: $225.21B; Shares Outstanding: 540.63M.
• Dividend Yield: 2.47%; Dividend Rate: $10.08; Ex-Dividend Date: 2026-08-21.
• Beta: 0.11 (low market sensitivity); 52-Week High: $447.03; 52-Week Low: $288.00.
• Institutional Ownership: 60.81%; Average Volume: 3,074,000; Historical Volatility: 40.14%.
• Revenue growth, gross/operating/net margins, Debt/Equity, ROE, and Free Cash Flow are null in data — not available for review.
• Forward P/E, PEG Ratio, Price/Book, target mean price, and analyst consensus are null — no valuation comparison or target context provided.
• Fundamentals show stable earnings and low beta, but lack of margin/data diverges from bullish technicals and bearish options sentiment.

Current Market Position

From DAILY and MINUTE data: Current price (2026-10-08 close) is $406.56. Minute bars show 2026-10-09 13:25 last close at $415.95, with intraday range $415.47–$416.18.

Recent daily action: 30-day range high $445.81 (2026-09-03), low $374.46 (2026-09-16). Price recovered from $374.46 to $424.37 (2026-09-29) then pulled back to $406.56.

Intraday momentum (10-09): opened $415.90, drifted to $415.95 at 13:25, low vol bars (<24k), slight upward bias from $415.47 at 13:10.

Technical Analysis

SMA alignment: SMA 5 (405.24) > SMA 20 (400.31) but < SMA 50 (411.37) — no golden cross, price below 50-day. RSI 62.22 shows bullish momentum not overbought. MACD positive histogram confirms bullish bias. Bollinger: middle $400.31, upper $431.08, lower $369.53 — price near upper third. 30-day range: price at $406.56 is 28.4% above low, 16.2% below high.

True Sentiment Analysis (Delta 40-60 Options)

Options flow (2026-10-09 13:56) via tru-sentiment methodology:

Call Volume: $2,867,910 (33.5%) Put Volume: $5,690,115 (66.5%) Total: $8,558,025

Sentiment: Bearish. Put dollar vol 2x calls. 136 of 2024 options analyzed (6.7% filter). Pure directional positioning suggests near-term downside expectation, diverging from bullish technicals (RSI/MACD).

Key Price Levels (observational only)